Praxis Precision Medicines 'A Diversified Player In Epilepsy Market,' Analyst Sees Over 100% Stock Upside

benzinga.com/25/05/45264709/praxis-precision-medicines-a-diversified-player-in-epilepsy-market-analyst-sees-over-100-stock-upside

Chardan Research initiated coverage on Praxis Precision Medicines, Inc. (NASDAQ:PRAX) on Wednesday, citing the potential of its epilepsy franchise.
Analyst Rudy Li writes, “Epilepsy remains one of our favorite markets in the CNS space, and we view Praxis as a diversified play in…

This story appeared on benzinga.com, 2025-05-07 19:26:16.
The Entire Business World on a Single Page. Free to Use →